LIFECORE BIOMEDICAL, INC. Litigation Settlement, Expense
LIFECORE BIOMEDICAL, INC. (LFCR) reported Litigation Settlement, Expense of $0 for the 3-month period ending 2020-11-29, per its 10-K filed 2024-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2024-03-20
- LIFECORE BIOMEDICAL, INC. litigation settlement, expense for the quarter ending 2020-11-29 was $0.00.
- LIFECORE BIOMEDICAL, INC. litigation settlement, expense for fiscal 2018 was $2.60M, a 0.00% change from fiscal 2017.
- LIFECORE BIOMEDICAL, INC. litigation settlement, expense for fiscal 2017 was $2.60M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 12 month |
|---|---|---|
| 2020-11-29 | $0.00 10-K · filed 2024-03-20 | |
| 2018-05-27 | $2.60M 10-K · filed 2018-08-09 | |
| 2017-05-28 | $2.60M 10-K · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |